The biggest red flag in online TRT care is a clinic willing to prescribe testosterone without baseline bloodwork or a real clinician review. Telehealth made testosterone replacement therapy far more accessible in 2026, but that same convenience has drawn in operators that skip the diagnostic steps a responsible provider would never cut, from a full hormone panel to ongoing monitoring once you're on treatment.
Why Telehealth TRT Grew So Fast
Testosterone is a Schedule III controlled substance, which historically meant clinicians needed an in-person exam before prescribing it. That changed during the COVID-19 public health emergency, when the DEA and HHS suspended the in-person requirement for controlled substance prescribing. The flexibility has been repeatedly extended since, most recently through a fourth temporary extension that keeps synchronous audio-video telehealth prescribing in place through December 31, 2026 (Federal Register, DEA/HHS Fourth Temporary Extension, 2025). That policy is what let dozens of direct-to-consumer TRT brands launch nationally without requiring patients to visit a physical office first.
The rule change was meant to preserve legitimate access, not eliminate the medical workup. A telehealth visit still has to meet a legitimate medical purpose standard, and the clinician still needs enough diagnostic information to justify the prescription (Telehealth.HHS.gov, Prescribing Controlled Substances via Telehealth). Clinics that treat the flexibility as a shortcut around bloodwork, rather than around the in-person visit, are misreading what the policy actually allows.
Red Flag: No Bloodwork Before Prescribing
A reputable provider will not prescribe testosterone based on a symptom questionnaire alone. Clinical guidance calls for confirming unequivocally low serum testosterone on more than one occasion before making a diagnosis, along with a baseline hematocrit and PSA check before starting therapy (Endocrine Society Clinical Practice Guideline, JCEM, 2018). If a clinic quotes you a price and a start date before a single lab has been drawn, that is the clearest sign something is being skipped.
Red Flag: An Incomplete Lab Panel
Some online clinics do order labs, but only a total testosterone test. A full workup should also include free testosterone, estradiol, hematocrit, SHBG, and typically LH and FSH to help identify the cause of low testosterone rather than just confirming the number. A panel that stops at total testosterone can miss a rising hematocrit or estradiol level that would otherwise change your dose or delivery method.
Red Flag: No Real Clinician Review
Look for a clear point in the process where a licensed physician, nurse practitioner, or physician assistant actually reviews your history and labs and can be reached with questions. A process that runs entirely on an automated questionnaire, with prescriptions generated without documented clinician sign-off, does not meet the legitimate medical purpose standard telehealth prescribing is supposed to satisfy.
Red Flag: No Follow-Up Monitoring
TRT is not a start-it-and-forget-it prescription. Guidelines call for ongoing clinical evaluation throughout treatment, not just at the initial visit, specifically to catch rising hematocrit, elevated estradiol, and other changes that show up only after your body adjusts to therapy (Endocrine Society Clinical Practice Guideline, JCEM, 2018). A clinic that never schedules a follow-up lab draw, or only reaches out to ask if you want a refill, is treating TRT like a subscription rather than a managed medical treatment.
